IP Group Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
31

- Investments
-
423
- Portfolio
-
123
- Exits
-
131

IP Group General Information
Description
Founded in 2001, IP Group is a venture capital firm based in London, United Kingdom. The firm seeks to invest in early-stage to mature businesses operating in the healthcare, life science, technology, cleantech, and biotechnology sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 2nd Floor, 3 Pancras Square
- King's Cross
- London N1C 4AG
- England, United Kingdom
+44 020 0000 0000
IP Group Investments & Acquisitions (423)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Abliva | 13-Jun-2022 | PIPE | 000.00 | Pharmaceuticals | Generating Revenue/Not Profitable | |
000 0000000000 | 26-May-2022 | 00000 00000 | 000.00 | Agricultural Chemicals | Generating Revenue | |
000000 | 03-May-2022 | 00000 00000 | 00.000 | Pharmaceuticals | Startup | |
000000 00000000000 | 02-May-2022 | 0000 00000 | 00.000 | Drug Discovery | Pre-Clinical Trials | 0000 00000 00.0 |
00000000 | 28-Apr-2022 | 00000 00000 | 000.00 | Business/Productivity Software | Generating Revenue | |
00000000 | 11-Apr-2022 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | 000000 00000000 00.0 |
00000 000000000000 | 07-Apr-2022 | 00000 00000 | 00.000 | Drug Discovery | Pre-Clinical Trials | 000000 000000000000 00.0 |
00000 | 15-Mar-2022 | 00000 00000 | 0000 | Plastic Containers and Packaging | Generating Revenue | |
Enterprise Therapeutics | 09-Mar-2022 | Later Stage VC | 00.000 | Drug Discovery | Generating Revenue | 00000 0000000000 00.0 |
Microbiotica | 07-Mar-2022 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | 000000 00000000 00.0 |
IP Group Exits (131)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Augmented Bionics | 12-Apr-2022 | Out of Business | |
00000000 | 01-Jan-2022 | 000000000 00000000 | |
00000000000 | 11-Oct-2021 | 000000000000000000 | 00.000 |
000000 00000000 00 | 30-Sep-2021 | 000 | 00000 |
00000000 | 14-Sep-2021 | 000 00 00000000 | |
00000000 00000000 | 14-Sep-2021 | 000 00 00000000 | |
00000000 00000000 | 17-Aug-2021 | 0000000000: 000000 | |
00000000000 | 02-Jul-2021 | 000000000000000000 | |
Structure Vision | 01-Jul-2021 | Secondary Transaction - Private | |
AVID Technology (Electrical Equipment) | 30-Jun-2021 | Merger/Acquisition |
IP Group Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
IP Group Investments by Industry, Year, and Region
IP Group Team (82)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Greg Smith | Chief Executive Officer, Executive Director and Member of the Board of Directors | 0 | London, United Kingdom | ||
Alan Aubrey | Chief Executive Officer, Executive Director, and Member of the Board of Directors | 00 | 0 | 0 | London, United Kingdom |
David Baynes | Chief Operating Officer, Executive Director and Member of the Board of Directors | 00 | 0 | 0 | London, United Kingdom |
Lewis Liu Ph.D | Managing Director, Greater China & China Head, Cleantech | 0 | 0 | 0 | London, United Kingdom |
Michael Molinari Ph.D | Managing Director, Australia | 0 | 0 | London, United Kingdom |
IP Group Co-Investors (238)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Parkwalk Advisors | 14 | 0 | 00 |
![]() |
![]() |
Oxford Science Enterprises | 0 | 0 |
![]() |
![]() |
|
Cambridge Enterprise | 0 | 0 |
![]() |
![]() |
|
Hostplus Superannuation Fund | 0 | 0 | 0 |
![]() |
![]() |
Touchstone Innovations | 0 | 0 | 0 |
![]() |
![]() |